Clinical Trials Browser

Phase EARLY_PHASE1 × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × nilotinib × Clear all

NCT03228303 2017-10-10

Nilotinib Versus Imatinib in Treatment of Patients With Newly Diagnosed Chronic Myeloid Leukemia

Phase EARLY_PHASE1 Unknown

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive